User contributions
From WikiPathways
(Latest | Earliest) View (newer 50) (older 50) (20 | 50 | 100 | 250 | 500)
- 20:15, 11 November 2024 Homo sapiens:Phosphoinositide 3-kinase (PI3K) family (Identify nodes)
- 19:56, 11 November 2024 Homo sapiens:Targeted therapy in breast cancer (Import parts of RAS / MAPK pathway)
- 19:50, 11 November 2024 N Homo sapiens:Targeted therapy in breast cancer (New pathway)
- 19:19, 11 November 2024 Homo sapiens:Chemical compounds to monitor proteins (Modified description) (top)
- 18:04, 11 November 2024 Homo sapiens:Tyrosine kinase inhibitors in glioblastoma (Ontology Term : 'drug pathway' added !)
- 18:03, 11 November 2024 Homo sapiens:Targeting YAP in pancreatic ductal adenocarcinoma (PDAC) (Ontology Term : 'drug pathway' added !)
- 17:13, 11 November 2024 Homo sapiens:Targeting YAP in pancreatic ductal adenocarcinoma (PDAC) (Ontology Term : 'pancreatic ductal cell' added !)
- 17:12, 11 November 2024 Homo sapiens:Targeting YAP in pancreatic ductal adenocarcinoma (PDAC) (Ontology Term : 'pancreatic ductal adenocarcinoma' added !)
- 17:02, 11 November 2024 Homo sapiens:Targeting YAP in pancreatic ductal adenocarcinoma (PDAC) (Connect downstream cell phenotypes)
- 16:52, 11 November 2024 Homo sapiens:Targeting YAP in pancreatic ductal adenocarcinoma (PDAC) (Add literature reference)
- 16:50, 11 November 2024 Homo sapiens:Targeting YAP in pancreatic ductal adenocarcinoma (PDAC) (Label cell type, organelle)
- 16:38, 11 November 2024 Homo sapiens:Targeting YAP in pancreatic ductal adenocarcinoma (PDAC) (Add CHEBI identifiers, refine labels)
- 16:26, 11 November 2024 Homo sapiens:Targeting YAP in pancreatic ductal adenocarcinoma (PDAC) (Connect nodes in mevalonate pathway)
- 16:21, 11 November 2024 Homo sapiens:Targeting YAP in pancreatic ductal adenocarcinoma (PDAC) (Add interactions, groups, complexes)
- 15:54, 11 November 2024 Homo sapiens:Targeting YAP in pancreatic ductal adenocarcinoma (PDAC) (Organize nodes)
- 15:33, 11 November 2024 N Homo sapiens:Targeting YAP in pancreatic ductal adenocarcinoma (PDAC) (New pathway)
- 04:40, 11 November 2024 Homo sapiens:Tyrosine kinase inhibitors in glioblastoma (Add ChEBI identifiers for TKIs)
- 04:30, 11 November 2024 Homo sapiens:Tyrosine kinase inhibitors in glioblastoma (Add PharmGKB identifiers)
- 03:49, 11 November 2024 Homo sapiens:Tyrosine kinase inhibitors in glioblastoma (Ontology Term : 'glial cell' added !)
- 03:41, 11 November 2024 Homo sapiens:Tyrosine kinase inhibitors in glioblastoma (Add RTK pathways)
- 03:28, 11 November 2024 Homo sapiens:Tyrosine kinase inhibitors in glioblastoma (Modified description)
- 03:18, 11 November 2024 Homo sapiens:Tyrosine kinase inhibitors in glioblastoma (Ontology Term : 'glioblastoma' added !)
- 03:09, 11 November 2024 Homo sapiens:Tyrosine kinase inhibitors in glioblastoma (Modified description)
- 02:58, 11 November 2024 Homo sapiens:Tyrosine kinase inhibitors in glioblastoma (Add literature reference)
- 02:33, 11 November 2024 Homo sapiens:Tyrosine kinase inhibitors in glioblastoma (Add more interactions, organelle, pathway containers)
- 20:03, 10 November 2024 Homo sapiens:Tyrosine kinase inhibitors in glioblastoma (Add more interactions)
- 19:55, 10 November 2024 Homo sapiens:Tyrosine kinase inhibitors in glioblastoma (Add interactions, labels)
- 17:35, 10 November 2024 Homo sapiens:Tyrosine kinase inhibitors in glioblastoma (Add more metabolites, identifiers)
- 14:17, 10 November 2024 N Homo sapiens:Tyrosine kinase inhibitors in glioblastoma (New pathway)
- 02:19, 9 November 2024 Homo sapiens:Mammary gland development: pregnancy and lactation - stage 3 of 4 (Fix PathVisio / Kaavio discrepancy with "double" line style)
- 02:17, 9 November 2024 Homo sapiens:Mammary gland development: pregnancy and lactation - stage 3 of 4 (Expand MAPK gene family)
- 02:01, 9 November 2024 Homo sapiens:Mammary gland development: pregnancy and lactation - stage 3 of 4 (Refine NFKB modeling as complex, not merely group)
- 01:57, 9 November 2024 Homo sapiens:Mammary gland development: pregnancy and lactation - stage 3 of 4 (Use gene symbol)
- 01:52, 9 November 2024 Homo sapiens:Mammary gland development: pregnancy and lactation - stage 3 of 4 (Expand NFI gene family)
- 13:52, 8 November 2024 Homo sapiens:Cigarette smoke induced lung fibrosis (Modified title) (top)
- 11:37, 30 October 2024 Homo sapiens:Mammary gland development: pregnancy and lactation - stage 3 of 4 (Refine interaction position)
- 23:52, 29 October 2024 Homo sapiens:Fumarate hydratase-deficient papillary renal cell carcinoma (Economize layout)
- 23:43, 29 October 2024 Homo sapiens:Type I interferon induction and signaling during SARS-CoV-2 infection (Tailor node width, standardize case) (top)
- 23:23, 29 October 2024 Homo sapiens:Type I interferon induction and signaling during SARS-CoV-2 infection (Economize layout)
- 16:45, 27 October 2024 Homo sapiens:Development and heterogeneity of the ILC family (Use gene symbols)
- 16:40, 27 October 2024 Homo sapiens:Fatty acid and lipoprotein transport in hepatocytes (Omit non-standard, formulaic, hidden complex names)
- 16:34, 27 October 2024 Homo sapiens:miR-targeted genes in squamous cell (Add literature reference) (top)
- 16:30, 27 October 2024 Homo sapiens:miR-targeted genes in muscle cell (Add literature reference) (top)
- 16:24, 27 October 2024 Homo sapiens:miR-targeted genes in epithelium (Add literature reference) (top)
- 16:22, 27 October 2024 Homo sapiens:miR-targeted genes in adipocytes (Add literature reference) (top)
- 16:18, 27 October 2024 Homo sapiens:miR-targeted genes in leukocytes (Add literature reference) (top)
- 16:15, 27 October 2024 Homo sapiens:miR-targeted genes in lymphocytes (Add literature reference) (top)
- 15:19, 27 October 2024 Homo sapiens:Kallmann syndrome (Fix newlines)
- 15:18, 27 October 2024 Homo sapiens:Kallmann syndrome (Remove unconnected satellite gene, fix newlines, standardize case)
- 12:22, 27 October 2024 Homo sapiens:NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence (Refine legend, node heights)
(Latest | Earliest) View (newer 50) (older 50) (20 | 50 | 100 | 250 | 500)
